Product Name: GTF2F1 (382-392) pS385+pT389
Product Number: PE-04AMS95
| Size: | 200 µg | Price: | 74.00 | |
| 1 mg | $US | 148.00 | ||
| 5 mg | 325.00 |
Peptide Name: GTF2F1 (382-392) pS385+pT389
Product Use: Services as a blocking peptide for use with the GTF2F1-pS385+pT389 rabbit polyclonal antibody (Cat. No.: AB-PK651) that is also available from Kinexus. This phosphopeptide may also be useful as a substrate for screening the phosphatase activity of protein phosphatases. The peptide sequence is located in the TFIIF_alpha domain. Phosphorylation inhibits transcriptional activity.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: RGN-pS-RPG-pT-PSA
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: βAla-Cys
Product Use: Services as a blocking peptide for use with the GTF2F1-pS385+pT389 rabbit polyclonal antibody (Cat. No.: AB-PK651) that is also available from Kinexus. This phosphopeptide may also be useful as a substrate for screening the phosphatase activity of protein phosphatases. The peptide sequence is located in the TFIIF_alpha domain. Phosphorylation inhibits transcriptional activity.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: RGN-pS-RPG-pT-PSA
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: βAla-Cys
Peptide Modifications Other: Phosphorylated
Peptide Molecular Mass Calculated: 1433.34 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: GTF2F1 - pS385+pT389 phosphosite-specific antibody (Cat. No.: AB-PK651)
Peptide Molecular Mass Calculated: 1433.34 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: GTF2F1 - pS385+pT389 phosphosite-specific antibody (Cat. No.: AB-PK651)
Scientific Background: GTF2F1 is a protein-serine/threonine kinase of the Atypical group and family. It is also a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It can be inhibited by mutation of S385 and T389.
© Kinexus Bioinformatics Corporation 2017